Ichnos Sciences
Corporate brand
UnclaimedIchnos Sciences is a New York-based biopharmaceutical company developing innovative therapies in oncology and immunology.
Last updated October 5, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
Ichnos Sciences is a biopharmaceutical company headquartered in New York, United States. The company is dedicated to the research and development of new therapeutic drug candidates, with a focus on oncology and immunology. As a commercial entity, Ichnos Sciences operates in the life sciences sector, aiming to bring innovative therapies to patients through its pipeline of drug candidates. The company is privately held and holds a position in the global biopharmaceutical industry. Its work involves preclinical and clinical development of biologics and small molecules, but specific details regarding its founding, leadership, and product portfolio are not provided in the available evidence. The company's official website is ichnossciences.com, which serves as the primary source for information about its activities and pipeline.
History
Ichnos Sciences is a biopharmaceutical company based in New York, United States. While the exact founding date and early history are not detailed in the available evidence, the company has established itself as a player in the biotechnology and pharmaceutical industry. It focuses on the discovery and development of novel therapies, particularly in the areas of oncology and immunology. The company's operations include research and development activities aimed at advancing drug candidates through preclinical and clinical stages. As a private entity, Ichnos Sciences collaborates with partners and investors to fund its pipeline. Its headquarters in New York positions it within a major hub for life sciences and pharmaceutical innovation. Further historical milestones, such as specific drug approvals or partnerships, are not available in the provided sources.
Products and positioning
Innovative biopharmaceutical company focused on oncology and immunology.
Recent events
Reported
Ichnos Sciences appoints Sonia Quaratino to its board[2]
Ichnos Sciences announced that Sonia Quaratino was appointed as an independent member of its Board of Directors.
Reported
Ichnos Sciences appoints Michael D. Price as CFO[3]
Ichnos Sciences named Michael D. Price as its Chief Financial Officer, effective immediately.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/ichnos-sciences-united-states · Editorial policy · How profiles are compiled